Although more than 88% of US people say they accept COVID-19 vaccination, 14% say they would only get vaccinated with compensation − payments of at least $US500 would be required to get 50% of these people to accept being vaccinated, according to research published in Applied Health Economics and Health Policy.
The study consisted of an online survey of 2000 US individuals aged ≥18 years that used a set of contingent valuation questions to estimate willingness-to-pay and willingness-to-accept values for the vaccine and to assess its association with vaccine efficacy levels (50%, 70%, and 95%). The authors note that data collection for the study was conducted after the US Food and Drug Administration (FDA) granted emergency authorisation for the Pfizer-BioNTech (11 December 2020) and Moderna (13 December 2020) vaccines at a time when the USA had
what was then the largest number of daily cases and deaths.
Sixty percent of the participants said they were willing to pay a positive amount for the vaccine; 13.7% said they would only accept free vaccination; 14.1% were willing to take the vaccine only if they were paid; and 12.2% would not accept the vaccine at all. Vaccine efficacy levels were found to affect demand for the vaccine. At vaccine efficacy levels of 50%, 75% and 95%, the estimated mean willingness-to-pay values were: $US594, $706, and $723, respectively.
The authors conclude that "payments of at least $525 are needed to sufficiently incentivise 50% or more of those willing to get vaccinated only if compensated."
Reference
- Carpio CE, et al. COVID-19 Vaccine Demand and Financial Incentives. Applied Health Economics and Health Policy : 5 Oct 2021. Available from: URL: 10.1007/s40258-021-00687-9 [DOI] [PMC free article] [PubMed]
